Pasco, WA, United States of America

Daniel Orton


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Liver Fibrosis Diagnosis by Daniel Orton

Introduction

Daniel Orton is an accomplished inventor based in Pasco, WA (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of liver fibrosis. With a total of 2 patents, his work focuses on innovative methods and systems for diagnosing and prognosing liver fibrosis.

Latest Patents

Orton's latest patents revolve around biomarkers for liver fibrosis. These patents provide methods and systems for diagnosing or prognosing liver fibrosis in a subject. The methods include detecting liver fibrosis-related molecules in a sample obtained from the subject. Furthermore, the expression of these molecules is compared to controls representing expression values expected in a subject without liver fibrosis or with non-progressing fibrosis. When differential expression of the molecules between the sample and the controls is detected, liver fibrosis can be diagnosed or prognosed. Additionally, kits for the diagnosis or prognosis of liver fibrosis are provided, which include reagents for detecting liver fibrosis-related molecules.

Career Highlights

Daniel Orton is currently associated with the Battelle Memorial Institute, where he continues to advance his research and innovations. His work has the potential to significantly impact the way liver fibrosis is diagnosed and managed.

Collaborations

Orton collaborates with notable colleagues, including Jon Morrell Jacobs and Kristin E Burnum-Johnson. Their combined expertise contributes to the development of effective diagnostic tools in the medical field.

Conclusion

Daniel Orton's innovative work in the diagnosis of liver fibrosis showcases his commitment to improving medical diagnostics. His contributions are paving the way for better patient outcomes in liver health management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…